S. Ramezaninejad

发表

The Effects of Thalidomide as an Adjuvant Treatment Besides of Dexamethasone and Remdesivir on Patients with Moderate COVID-19

A. Hakamifard, Hamed Azhdari Tehrani, M. Darnahal, 2021, SSRN Electronic Journal.

Hematologic malignancies and COVID‐19 infection: A monocenter retrospective study

M. Mardani, A. Hakamifard, Hamed Azhdari Tehrani, 2022, Health science reports.

Rituximab Utilization Evaluation with Focused on Available Evidence for Off-Labeled Indications

N. Rezaie, B. Ghanbari, M. Motamed, 2019, Journal of Pharmaceutical Care.

The Utilization Pattern of Caspofungin in an Educational Hospital

M. Ranjbar, B. Ghanbari, A. Amouzegar, 2020 .